An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibility

Pos, Karin; Wit, Iris E. de; Dijk, Floor A. van; Bartels-Velthuis, Agna A.; Bruggeman, Richard; Meijer, Carin J.; Haan, Lieuwe de; Alizadeh, Berhooz Z.; Beveren, Nico J.M. van; Cahn, Wiepke; Delespaul, Philippe; Myin-Germeys, Inez; Kahn, René S.; Schirmbeck, Frederike; Simons, Claudia; Haren, Neeltje E. van; Os, Jim van; Winkel, Ruud van

doi:10.1016/j.psychres.2017.08.017

Cited by 6 publications

(5 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Five studies compared individuals with psychosis to relatives and all studies demonstrated higher emotional stress reactivity in those with psychosis compared to relatives (Frissen et al, 2014; Habets et al, 2012; Lataster et al, 2010; Myin‐Germeys et al, 2001; Pos et al, 2017). Three studies compared emotional stress reactivity between relatives and controls and all studies found no significant difference (Collip, Nicolson, et al, 2011; Frissen et al, 2014; Habets et al, 2012).…”

Section: Resultsmentioning

confidence: 99%

“…Three studies compared emotional stress reactivity between relatives and controls and all studies found no significant difference (Collip, Nicolson, et al, 2011; Frissen et al, 2014; Habets et al, 2012). The only quality issues identified were high rates of excluded participants and a lack of gender covariate in Pos et al (2017) and Myin‐Germeys et al (2001). Rauschenberg et al (2017) compared emotional stress reactivity in mental health service users, with higher levels of psychotic symptoms, with siblings of service users.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

A systematic review and meta‐analysis of the association between emotional stress reactivity and psychosis

Muddle

Jones

Taylor

et al. 2021

Early Intervention Psych

View full text Add to dashboard Cite

Aim Emotional stress reactivity may be a mediating factor in the association between trauma and psychosis. This review aimed to (i) identify, summarise and critically evaluate the link between emotional stress reactivity and psychotic experiences (ii) examine evidence for a 'dose–response' relationship between stress reactivity and psychosis in the wider psychosis phenotype (i.e., sub‐clinical symptoms). Methods Electronic database searches (PsychINFO, MEDLINE, EMBASE) were conducted for studies which investigated the link between stress reactivity and psychosis, psychotic symptoms, or a vulnerability to developing psychosis (wider phenotype). Cross‐sectional, experimental and experience sampling method study designs were eligible for inclusion. Results Fourty five eligible articles were identified (N participants = 8830). Narrative synthesis showed that increased emotional stress reactivity was associated with psychosis and subclinical psychotic experiences across all study designs, however, findings were inconsistent across studies. The preliminary meta‐analysis (k = 4, n = 383) showed increases in emotional stress reactivity was associated with higher negative affect in response to event‐related stress, in those with psychosis compared to controls (mean difference in beta coefficients = 0.05, 95% CI 0.02–0.08, p = .004). However, this difference was small with a considerable degree of heterogeneity (p = .001, I2 = 81%) so results should be interpreted with caution. Conclusions Overall, the evidence suggests that there is a link between emotional stress reactivity and psychosis in those with psychosis, those at high risk of developing psychosis and in relation to subclinical psychotic‐like experiences in the general population.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

A systematic review and meta‐analysis of the association between emotional stress reactivity and psychosis

Muddle

Jones

Taylor

et al. 2021

Early Intervention Psych

View full text Add to dashboard Cite

show abstract

“…Positive and negative affect have been shown to be reliable and valid constructs (Eisele et al, 2021; Myin-Germeys et al, 2000). Affective intensity has been shown to be significantly associated with subjective well-being (Pos et al, 2017) and may be adversely affected by a reduction of dopaminergic neurotransmission associated with antipsychotic use (Lataster et al, 2011).…”

Section: Methodsmentioning

confidence: 99%

Monitoring momentary subjective well-being and psychotic experiences during antipsychotic dose reduction: Two single-case time series experience sampling method pilot study.

Oomen,

Simons,

Broekmans-Madikrama

et al. 2024

Psychiatric Rehabilitation Journal

View full text Add to dashboard Cite

Objective: Personalized dose optimization is desirable to improve subjective well-being and support rehabilitation. Therefore, N = 1 trials investigating tools to self-manage functional outcomes during dose optimization are necessary. The aim of this pilot study was to determine in two N = 1 trials whether an experience sampling method (ESM) smartphone app could be used to monitor and detect changes in subjective well-being and psychotic experiences during and after dose reduction. Method: Two participants with a psychotic disorder in remission underwent gradual dose reduction under a longitudinal selfmonitoring paradigm, accompanied by regular clinical monitoring by the attending physician. Subjective well-being was monitored with an (ESM) app through momentary affective experience (positive and negative affect) and physical well-being (tiredness, feeling unwell, and pain). Momentary psychotic experiences were assessed with four items. Time-series linear regression models were used to detect changes in reduction phases compared to baseline. Results: Whereas significant improvements in subjective wellbeing and psychotic experiences during dose reduction were detected in one participant, the opposite was demonstrated for the other participant, showing worsened subjective well-being and increased psychotic experiences in the reduction phase compared to baseline. Conclusions and Implications for Practice: Selfmonitoring with an ESM smartphone app offers a tool for detecting changes in subjective well-being and psychotic experiences during antipsychotic dose reduction. In this way, ESM may increase an individual's sense of control and empowerment. It may further facilitate dose optimization and shared decision-making at an individual level, which is required considering the high heterogeneity in psychotic disorders. Impact and ImplicationsThe present study shows that subtle changes in momentary subjective well-being and psychotic experiences during dose reduction can be identified with the experience sampling method. Whereas one participant reported an increase in subjective well-being and fewer psychotic experiences, the other participant reported a decrease in subjective well-being and increased psychotic experiences. These results further indicate substantial heterogeneity and underscore the importance of exploring and monitoring dose optimization at an individual level. Experience sampling method smartphone technology may be a suitable tool to facilitate early signaling of meaningful psychological changes and self-management of outcomes during antipsychotic dose optimization. Furthermore, it may promote rehabilitation by increasing an individual's sense of control and empowerment, and it may guide shared decision-making during the process of dose reduction.

show abstract

“…We therefore investigated whether starting dose of amisulpiride predicts SR. Moreover, SR on antipsychotic medication is not only related to factors associated with medication but there are indications that a substantial part of the variation in SR is related to demographical or clinical differences between patients (Pos et al, 2017 ; van Dijk, Schirmbeck, & Haan, 2018 ). Knowledge concerning individual risk factors for an unfavorable or dysphoric response would enable patient selection for specific strategies to ameliorate SR.…”

mentioning

confidence: 99%

Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background Subjective response (SR) to antipsychotic medication is relevant for quality of life, adherence and recovery. Here, we evaluate (1) the extent of variation in SR in patients using a single antipsychotic; (2) the association between subjective and symptomatic response; and (3) predictors of SR. Methods Open-label, single treatment condition with amisulpride in 339 patients with a first episode of a schizophrenia spectrum disorder, at most minimally treated before inclusion. Patients were evaluated at baseline, before start with amisulpride and after four weeks of treatment with the Subjective Wellbeing under Neuroleptic scale, the Positive and Negative Syndrome Scale, and the Calgary Depression Scale for Schizophrenia. Results (1) 26.8% of the patients had a substantial favorable SR, and 12.4% of the patients experienced a substantial dysphoric SR during treatment with amisulpride. (2) Modest positive associations were found between SR and 4 weeks change on symptom subscales (r = 0.268–0.390, p values < 0.001). (3) Baseline affective symptoms contributed to the prediction of subjective remission, demographic characteristics did not. Lower start dosage of amisulpride was associated with a more favorable SR (r = −0.215, p < 0.001). Conclusions We conclude that variation in individual proneness for an unfavorable SR is substantial and only modestly associated with symptomatic response. We need earlier identification of those most at risk for unfavorable SR and research into interventions to improve SR to antipsychotic medication in those at risk.

show abstract

An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibility

Cited by 6 publications

References 37 publications

A systematic review and meta‐analysis of the association between emotional stress reactivity and psychosis

A systematic review and meta‐analysis of the association between emotional stress reactivity and psychosis

Monitoring momentary subjective well-being and psychotic experiences during antipsychotic dose reduction: Two single-case time series experience sampling method pilot study.

Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders

Contact Info

Product

Resources

About